Was Claudia Munce’s Arteris (AIP) share grant an open-market purchase?

No, the 860-share grant to Claudia F. Munce was a fully vested restricted stock award representing retainer fees taken in shares instead of cash. The transaction is coded as a grant or award acquisition, not an open-market buy, and carries a per-share price of $0.00 in the filing.

Director Claudia Munce (AIP) takes 860 Arteris shares as deferred retainer

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Arteris, Inc. director Claudia F. Munce received a grant of 860 shares of fully vested restricted common stock as part of her board retainer. The shares represent fees she chose to take in stock instead of cash, based on an average trading price of $15.98 for Arteris common stock between February 20, 2026 and April 2, 2026. After this compensation-related acquisition, she holds 101,711 shares directly. The filing notes she elected to defer the receipt of these shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Munce Claudia F.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	860	$0.00	--

Holdings After Transaction: Common Stock — 101,711 shares (Direct)

Footnotes (1)

Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on April 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from February 20, 2026 through April 2, 2026, which was $15.98. The Reporting Person elected to defer the receipt of shares.

Key Figures

Restricted stock grant: 860 shares Average trading price: $15.98 Holdings after grant: 101,711 shares +2 more

5 metrics

Restricted stock grant 860 shares Fully vested restricted stock granted April 5, 2026 as retainer fees

Average trading price $15.98 Average Arteris common stock price Feb 20, 2026–Apr 2, 2026 used for grant

Holdings after grant 101,711 shares Total Arteris common stock directly held by Claudia F. Munce after transaction

Grant transaction price $0.00 per share Director compensation award, not an open-market purchase

Grant date April 5, 2026 Date of restricted stock grant to Claudia F. Munce

Key Terms

restricted stock, retainer fees, average trading price, defer the receipt of shares, +1 more

5 terms

restricted stock financial

"Fully vested restricted stock. The restricted stock represents retainer fees..."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

retainer fees financial

"represents retainer fees that the Reporting Person elected to receive..."

average trading price financial

"based on the average trading price of Arteris, Inc. common stock..."

defer the receipt of shares financial

"The Reporting Person elected to defer the receipt of shares."

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

04/07/2026 - 04:27 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Munce Claudia F.

(Last)

(First)

(Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL

CALIFORNIA

95008

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/05/2026		A		860⁽¹⁾⁽²⁾	A	$0.00	101,711	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on April 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from February 20, 2026 through April 2, 2026, which was $15.98.

2. The Reporting Person elected to defer the receipt of shares.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Munce Claudia F.	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Arteris (AIP) report for Claudia Munce?

Arteris reported that director Claudia F. Munce received 860 shares of fully vested restricted common stock as board retainer fees, taken in stock instead of cash. This is a compensation grant, not an open-market purchase or sale, and increases her direct holdings.

How many Arteris (AIP) shares does Claudia Munce hold after the latest grant?

Following the 860-share restricted stock grant, Claudia F. Munce directly holds 101,711 shares of Arteris common stock. The additional shares come from retainer fees she elected to receive in stock, reflecting routine director compensation rather than market trading activity.

What price was used to determine Claudia Munce’s Arteris (AIP) stock retainer?

The 860-share restricted stock grant to Claudia F. Munce was valued using an average Arteris common stock trading price of $15.98. This average covered the period from February 20, 2026 through April 2, 2026 and set the share amount for her retainer fees.

Did Claudia Munce defer receipt of her Arteris (AIP) restricted stock?

Yes. A footnote explains that Claudia F. Munce elected to defer the receipt of the granted shares. Although the award covers 860 fully vested restricted shares for retainer fees, the actual delivery of those shares to her is deferred under her election.